ZA

Zoheb Ahmed Khan

Active Director Director DIN 09062454
DIN 09062454 First appointment Feb 2021 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2021
Shareholding value •••• Premium profile

About Zoheb Ahmed Khan

Data last updated:

Zoheb Ahmed Khan is a Director at Kwykwel Pharma Private Limited (since 2021). The company operates in Trading. Kwykwel Pharma Private Limited reported revenue of ₹4.02 Cr (FY 2025).

DIN 09062454
Primary Designation Director
Industry Trading
First Appointment 10 Feb 2021
Oldest Company Age 5 yrs
Largest company Kwykwel Pharma Private Limited · ₹4.02 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kwykwel Pharma Private Limited U51909MH2021PTC354993
Director10 Feb 20212021₹4.02 Cr (FY 2025)Active

Board colleagues of Zoheb Ahmed Khan

Directorship timeline

Open interactive timeline →
Kwykwel Pharma Private Limited
Premium access

Shareholding and investment profile for Zoheb Ahmed Khan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Zoheb Ahmed Khan

Zoheb Ahmed Khan currently holds 1 directorship: Kwykwel Pharma Private Limited (Director, since 10 Feb 2021, revenue ₹4.02 Cr (FY 2025)).

Zoheb Ahmed Khan was first appointed on 10 Feb 2021 as Director at Kwykwel Pharma Private Limited.

The current boards of Zoheb Ahmed Khan's companies include Danish Ahmad Khan Shakil Ahmad Khan (Kwykwel Pharma Private Limited), Dinkar Sadashiv Varge (Kwykwel Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available